News from neurotrope, inc A wide array of domestic and global news stories; news topics include politics / government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages, as well.

Nov 20, 2014, 08:30 ET

Neurotrope Announces Last Patient Dosed in Phase 2a Clinical Trial of Bryostatin-1 for Alzheimer's Disease

 Neurotrope, Inc. (OTCQB: NTRP) announced today that the last patient has been dosed in its Phase 2a clinical trial of Bryostatin-1 for the...

Nov 06, 2014, 08:30 ET

Neurotrope Appoints Warren W. Wasiewski, M.D. as Executive Vice President, Development and Chief Medical Officer

Neurotrope, Inc. (OTCQB: NTRP) today announced that Warren W. Wasiewski, M.D., F.A.A.P. has joined Neurotrope BioScience, Inc., the Company's...

Sep 18, 2014, 08:30 ET

Larry D. Altstiel, M.D., Ph.D. Joins Neurotrope Board of Directors

 Neurotrope, Inc. (OTCQB: NTRP) today announced the appointment of Larry D. Altstiel, M.D., Ph.D. to the Company's Board of Directors,...

Aug 20, 2014, 13:30 ET

Neurotrope To Host Conference Call

Neurotrope, Inc. (OTCQB: NTRP) today announced that it will host a conference call to provide an update on Company activities. Access...

Aug 18, 2014, 09:13 ET
Jul 29, 2014, 08:30 ET

Neurotrope Initiates Phase 2a Study of Bryostatin for the Treatment of Alzheimer's Disease - Doses First Patients

 Neurotrope, Inc. (OTCQB: NTRP) announced today that it has initiated a Phase 2a clinical trial to evaluate bryostatin for the treatment of...

Jul 22, 2014, 08:30 ET

Neurotrope Enters Collaborative Agreement with Icahn School of Medicine at Mount Sinai for use of Bryostatin-1 in the Treatment of Niemann-Pick Disease Type C

 Neurotrope Bioscience, Inc., a subsidiary of Neurotrope, Inc. (OTCQB: NTRP) has signed a world-wide, exclusive license agreement with the...

Jul 18, 2014, 13:04 ET

Neurotrope Board of Directors Appoints Chairmen Ramat and Freiman as Interim Co-CEOs

 Neurotrope, Inc. (OTCQB: NTRP) today announced that on July 16, 2014,  its Board of Directors appointed Co-Chairmen Charles S. Ramat and...

Jun 19, 2014, 08:30 ET

Neurotrope Appoints Charles S. Ramat and Paul Freiman as Co-Chairmen of the Board

 Neurotrope, Inc. (OTCQB: NTRP) has appointed Messrs. Charles S. Ramat and Paul Freiman as Co-Chairmen of its Board of Directors. Mr. Freiman...

Jun 04, 2014, 08:30 ET

Neurotrope Appoints Neuroscientist Sam Kongsamut as Executive Director, Pharmacology

 Neurotrope, Inc. (OTCQB: NTRP) announced today the appointment of Sam Kongsamut, Ph.D., as Executive Director, Pharmacology, effective...

May 28, 2014, 08:30 ET

Neurotrope Announces Publication of Positive Human Cell Culture and Mouse Model Data of Bryostatin 1

 Neurotrope, Inc. (OTCQB: NTRP) announced today the publication of positive human cell culture and mouse model data of Bryostatin 1 in two peer...

May 20, 2014, 08:30 ET

Neurotrope, Inc. Collaborating with Dr. Paul Wender and Stanford University on Bryostatin Analogues

 Neurotrope, Inc. (OTCQB: NTRP) (the "Company") announced today that it has signed an agreement with Stanford University to study and, along...

Jan 28, 2014, 08:30 ET

Neurotrope, Inc., Hires Three Experienced Senior Pharmaceutical Executives - A Chief Medical Officer and Heads of Commercial Operations and Regulatory Affairs

 Neurotrope, Inc. (OTCQB: NTRP) (the "Company") announced today that it has hired Dr. Richard Scheyer as Vice President and Chief Medical...

Jan 14, 2014, 08:30 ET

Neurotrope, Inc., to Present at Noble Financial Tenth Annual Equity Conference in Sandpiper Bay, Florida

 Neurotrope, Inc. (OTCQB: NTRP) (the "Company") announced today that Dr. James New, the Company's President and Chief Executive Officer, will...

Jan 06, 2014, 08:30 ET

Neurotrope, Inc., to Present at Biotech Showcase 2014 in San Francisco

Neurotrope, Inc. (OTCQB: NTRP) (the "Company") announced today that the Company will present at the Biotech Showcase 2014 conference 8:00AM Pacific...

Dec 16, 2013, 08:30 ET

Neurotrope, Inc., Appoints James Gottlieb to the Company's Board of Directors

 Neurotrope, Inc. (OTCQB: NTRP) (the "Company") announced today that James Gottlieb has been appointed to the Company's Board of Directors....

Oct 22, 2013, 08:30 ET

Neurotrope, Inc., Appoints Paul E. Freiman to the Company's Board of Directors

 Neurotrope, Inc. (OTCQB:NTRP) (the "Company") announced today that Paul E. Freiman has been appointed to the Company's Board of...

Oct 15, 2013, 08:30 ET

Neurotrope, Inc., Announces Dr. Larry D. Altstiel, M.D., Ph.D. Appointed to the Company's Scientific Advisory Board

Neurotrope, Inc. (OTCQB:NTRP) (the "Company") announced today that Dr. Larry D. Altstiel, M.D., Ph.D. has been appointed to the Company's Scientific...

Oct 09, 2013, 08:30 ET

Neurotrope, Inc. Announces Closing of Additional $1.08 Million of its Private Offering

 Neurotrope, Inc. (OTCQB: NTRP) (the "Company") announced today that it completed a closing of the sale of 1,080,000 shares of its Series A...

Oct 07, 2013, 08:30 ET

Neurotrope, Inc., Announces Hiring Robert Weinstein As Executive Vice President and Chief Financial Officer

Neurotrope, Inc. (formerly BlueFlash Communications, Inc.) (OTCQB: NTRP), a Nevada corporation (the "Company"), announced today that it has...